We are live on ! Find out more
RMCM

Reynders McVeigh Capital Management Portfolio holdings

AUM $1.98B
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
+1.12%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$704M
AUM Growth
+$17.6M
Cap. Flow
+$17.6M
Cap. Flow %
2.5%
Top 10 Hldgs %
34.59%
Holding
228
New
17
Increased
78
Reduced
95
Closed
3

Top Buys

Rank Stock Value
1
SJM icon
J.M. Smucker
SJM
+$2.94M
2
PYPL icon
PayPal
PYPL
+$2.45M
3
NVO
Novo Nordisk
NVO
+$2.38M
4
ADI icon
Analog Devices
ADI
+$1.8M
5
ADNT icon
Adient
ADNT
+$1.65M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.63M
2
IPGP icon
IPG Photonics
IPGP
+$1.49M
3
PRGO icon
Perrigo
PRGO
+$1.24M
4
KR icon
Kroger
KR
+$1.05M
5
GILD icon
Gilead Sciences
GILD
+$990K

Sector Composition

Rank Sector Weight
1 Healthcare 25.52%
2 Technology 19.56%
3 Industrials 16.26%
4 Consumer Staples 11.7%
5 Financials 8.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLK icon
226
Blackrock
BLK
$178B
-760
Closed -$275K
CERN
227
DELISTED
Cerner Corp
CERN
-4,310
Closed -$266K
IM
228
DELISTED
Ingram Micro
IM
-7,500
Closed -$267K

Similar funds

Reynders McVeigh Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Reynders McVeigh Capital Management held 228 positions worth $704M, up 2.6% from $686M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Reynders McVeigh Capital Management's Q4 2016 filing shows 17 new, 78 increased, 95 reduced and 3 closed positions. Its largest new stake was Adient: 31,202 shares worth $1.83M. The largest sale was Teva Pharmaceuticals, an estimated $1.63M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Industrials.

  • Reynders McVeigh Capital Management's largest Q4 2016 buy was Adient: 31,202 shares worth $1.83M.
  • Reynders McVeigh Capital Management added most to J.M. Smucker in Q4 2016, an estimated $2.94M increase.
  • Reynders McVeigh Capital Management's biggest Q4 2016 reduction was Teva Pharmaceuticals, cutting an estimated $1.63M.
  • Reynders McVeigh Capital Management fully exited Blackrock in Q4 2016, selling an estimated $275K.
  • Reynders McVeigh Capital Management's ten largest holdings make up 35% of its $704M portfolio in Q4 2016.
  • Reynders McVeigh Capital Management opened 17 new positions and closed 3 in Q4 2016.
  • Reynders McVeigh Capital Management's portfolio value rose 2.6% quarter-over-quarter to $704M.

Based on Reynders McVeigh Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.